Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats

BACKGROUND: Treatment with metformin, the biguanide of hepatic insulin sensitizer, in patients with non-alcoholic fatty liver disease (NAFLD) has been reported with contradictory findings regarding the effectiveness on blood lipids and liver histology. In this study, we aimed to explore the preventi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetol Metab Syndr
Hlavní autoři: Sui, Yi, Kong, Xianhe, Fan, Rongrong, Ye, Yanbin, Mai, Haiyan, Zhuo, Shuyu, Lu, Wei, Ruan, Peishan, Fang, Shi, Yang, Tao
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852932/
https://ncbi.nlm.nih.gov/pubmed/31749893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-019-0491-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky